Objective: To evaluate perioperative outcomes and early survival in a series of octogenarians who underwent radical cystectomy (RC) and urinary diversion for bladder cancer. Patients and Methods: We retrospectively evaluated the clinical records of 44 patients aged ≥80 years who underwent open RC and urinary diversion at 2 high-volume centers between July 2013 and December 2015. Estimated blood loss (EBL), transfusion rate, and length of hospital stay (LOS) were evaluated. Ninety-day postoperative complications were stratified according to the type of urinary diversion. Univariable analysis was performed to identify predictors of overall and major complications. Overall survival (OS) was estimated using the Kaplan-Meier method. Results: Median age was 83 years (interquartile range [IQR] 81-85). Age-adjusted Charlson score was ≥4 in 37 (84%) patients, and American Society of Anesthesiologists score was ≥3 in 34 (77%) patients. Ileal conduit (IC) was performed in 21/44 (48%) cases, cutaneous ureterostomy (CU) in 20/44 (45%), and no urinary diversion was required for 3 (7%) dialytic patients. Median EBL was 700 mL (IQR 500-1,000) and 23 (52%) patients required blood transfusion. Median LOS was 13 days (IQR 10-18). Overall complications were recorded in 29 (66%) patients, with major complications observed in 12 (27%), with death occurring in 1. No differences in complications were observed between IC and CU. The 2-year OS estimate was 62.5%. Conclusions: Open RC in octogenarians has an acceptable rate of major complications and mortality. IC should be considered a good urinary diversion in these patients.

Keywords:
Radical cystectomy, Elderly patients, Octogenarians, Perioperative complications, Overall survival, Bladder cancer, Urothelial carcinoma, Urinary diversion
1.
Siegel RL, Miller KD, Jemal A: Cancer statistics, 2016. CA Cancer J Clin 2016;66:7-30.
2.
Shariat SF, Milowsky M, Droller MJ: Bladder cancer in the elderly. Urol Oncol 2009;27:653-667.
3.
Gore JL, Litwin MS, Lai J, et al: Use of radical cystectomy for patients with invasive bladder cancer. J Natl Cancer Inst 2010;102:802-811.
4.
Fedeli U, Fedewa SA, Ward EM: Treatment of muscle invasive bladder cancer: evidence from the National Cancer Database, 2003 to 2007. J Urol 2011;185:72-78.
5.
Nielsen ME, Shariat SF, Karakiewicz PI, et al: Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. Eur Urol 2007;51:699-706.
6.
Schiffmann J, Gandaglia G, Larcher A, et al: Contemporary 90-day mortality rates after radical cystectomy in the elderly. Eur J Surg Oncol 2014;40:1738-1745.
7.
Izquierdo L, Peri L, Leon P, et al: The role of cystectomy in elderly patients - a multicentre analysis. BJU Int 2015;116(suppl 3):73-79.
8.
Chamie K, Hu B, Devere White RW, Ellison LM: Cystectomy in the elderly: does the survival benefit in younger patients translate to the octogenarians? BJU Int 2008;102:284-290.
9.
Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383.
10.
Novara G, De Marco V, Aragona M, et al: Complications and mortality after radical cystectomy for bladder transitional cell cancer. J Urol 2009;182:914-921.
11.
Wallace DM: Uretero-ileostomy. Br J Urol 1970;42:529-534.
12.
Sobin LH GM, Wittekind C: TNM Classification of Malignant Tumors UICC International Union against Cancer, ed 7). 2009.
13.
Dindo D, Demartines N, Clavien PA: Classification of surgical complications: a new proposal with evaluation in a cohort of 6,336 patients and results of a survey. Ann Surg 2004;240:205-213.
14.
Grubmueller B, Seitz C, Shariat SF: The treatment of muscle-invasive bladder cancer in geriatric patients. Curr Opin Urol 2016;26:160-164.
15.
Bassett JC, Eifler JB, Resnick MJ, Clark PE: Developments and controversies in the management of noninvasive bladder cancer. Curr Opin Oncol 2014;26:299-304.
16.
Sikic D, Wach S, Taubert H, et al: How octogenarians with bladder cancer are treated in a maximum-care hospital: the real-life experience. Urol Int 2016, Epub ahead of print.
17.
Bruins HM, Veskimae E, Hernandez V, et al: The impact of the extent of lymphadenectomy on oncologic outcomes in patients undergoing radical cystectomy for bladder cancer: a systematic review. Eur Urol 2014;66:1065-1077.
18.
Lance RS, Dinney CP, Swanson D, et al: Radical cystectomy for invasive bladder cancer in the octogenarian. Oncol Rep 2001;8:723-726.
19.
Ogawa A, Yanagisawa Y, Nakamoto T, Wajiki M, Hirabayashi N, Nakama M: Treatment of bladder carcinoma in patients more than 80 years old. J Urol 1985;134:889-891.
20.
Horovitz D, Turker P, Bostrom PJ, et al: Does patient age affect survival after radical cystectomy? BJU Int 2012;110:E486-E493.
21.
Yamanaka K, Miyake H, Hara I, Inoue TA, Fujisawa M: Significance of radical cystectomy for bladder cancer in patients over 80 years old. Int Urol Nephrol 2007;39:209-214.
22.
Martin RC 2nd, Brennan MF, Jaques DP: Quality of complication reporting in the surgical literature. Ann Surg 2002;235:803-813.
23.
Longo N, Imbimbo C, Fusco F, et al: Complications and quality of life in elderly patients with several comorbidities undergoing cutaneous ureterostomy with single stoma or ileal conduit after radical cystectomy. BJU Int 2016;118:521-526.
24.
Wuethrich PY, Vidal A, Burkhard FC: There is a place for radical cystectomy and urinary diversion, including orthotopic bladder substitution, in patients aged 75 and older: results of a retrospective observational analysis from a high-volume center. Urol Oncol 2016;34:58.e19-e27.
25.
Hollenbeck BK, Miller DC, Taub D, et al: Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older. Urology 2004;64:292-297.
26.
Martini T, Mayr R, Wehrberger C, et al: Comparison of radical cystectomy with conservative treatment in geriatric ≥80 patients with muscle-invasive bladder cancer. Int Braz J Urol 2013;39:622-630.
27.
Nguyen DP, Al Hussein Al Awamlh B, Charles Osterberg E, et al: Postoperative complications and short-term oncological outcomes of patients aged ≥80 years undergoing robot-assisted radical cystectomy. World J Urol 2015;33:1315-1321.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.